Patents Examined by Jennifer A Berrios
  • Patent number: 10835512
    Abstract: Compositions and methods for the treatment of respiratory syncytial virus infections are provided.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: November 17, 2020
    Assignee: Respivant Sciences GmbH
    Inventors: Pravin Soni, William Gerhart, Manfred Keller, Ahmet Tutuncu
  • Patent number: 10828321
    Abstract: Formulations containing reactive oxygen species (ROS), processes for making these formulations, and methods of using these formulations are described. The formulations can include gels or hydrogels that contain at least one reactive oxygen species (ROS). The formulations can include a composition containing a reduced species (RS) and a reactive oxygen species (ROS). The formulations can also contain a rheology modifier and can include gels or hydrogels. Methods of preparing the formulations can include preparing a composition. Compositions can be prepared by providing water, purifying the water to produce ultra-pure water, combining sodium chloride to the ultra-pure water to create salinated water, and electrolyzing the salinated water at a temperature between about 4.5 to about 5.8° C.
    Type: Grant
    Filed: March 20, 2017
    Date of Patent: November 10, 2020
    Assignee: RDG HOLDINGS, INC.
    Inventor: Andrew Hoover
  • Patent number: 10765617
    Abstract: Disclosed herein is a personal care conditioning and/or styling composition for keratin substrate comprising: (A) at least one conditioning and/or styling copolymer obtained from polymerizing: (i) about 0.1 wt. % to 99.9 wt. % of at least one cationic or pseudo-cationic monomer selected from the group consisting of acrylamidopropyl trimethylammonium chloride (APT AC) and/or diallyl dimethyl ammonium chloride (DADMAC); and (ii) about 0.1 wt. % to 99.9 wt. % of at least one monomer comprising at least one functionalized or unfunctionalized acryloyl moiety and at least one lactam moiety; (B) at least one cosmetically acceptable excipient; and (C) optionally, at least one effective amount of personal care active ingredient. Also disclose is a process for preparing such composition and method of use thereof.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: September 8, 2020
    Inventors: Amna Khatun, David Petty, Lidia Kulcsar
  • Patent number: 10751270
    Abstract: The invention relates to a new composition in the form of a translucent, advantageously transparent, gel, without triethanolamine, comprising at least a fatty body in the form of an oleic acid an aqueous phase; and a base or a mixture of bases. The invention also relates to compositions, advantageously cosmetic compositions, comprising said gel base, such as a shaving gel. The invention also relates to a method for preparing said gel base, a shaving method, the use of said gel base and a shaving kit.
    Type: Grant
    Filed: January 25, 2016
    Date of Patent: August 25, 2020
    Inventors: Alex Chauvin, Laurent Dodet, Jean-Marie Total
  • Patent number: 10729663
    Abstract: The present invention provides a sustained drug delivery system for the treatment of age-related macular degeneration (AMD), comprising corticosteroid encapsulated nanoparticles incorporated into a thermoreversible hydrogel. The corticosteroid may be triamcinolone acetate (TA), dexamethasone, or loteprednol etabonate (LE). The proposed drug delivery system is nontoxic to ARPE-19 (retinal pigment epithelium) cells and significantly reduces VEGF (vascular endothelial growth factor) expression as compared to solutions of the coticosteroids. The present invention provides sustained delivery of the corticosteroid to the posterior segment of the eye, reducing the frequency of intraocular injections necessary to maintain therapeutic concentrations.
    Type: Grant
    Filed: August 22, 2016
    Date of Patent: August 4, 2020
    Assignee: University of South Florida
    Inventors: Vijaykumar Bhadabhai Sutariya, Anjali A. Hirani, Yashwant V. Pathak
  • Patent number: 10702607
    Abstract: Disclosed are pharmaceutical compositions comprising oxycodone and an oxycodone-processing enzyme, wherein oxycodone is contained in the pharmaceutical composition in a storage stable, enzyme-reactive state and under conditions wherein no enzymatic activity acts on oxycodone.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: July 7, 2020
    Assignee: G.L. PHARMA GMBH
    Inventors: Georg Guebitz, Katrin Greimel, Martin Brandauer, Daniela Huber, Klaus Bleymaier, Wolfgang Kroutil, Doris Lechner, Christof Wachter, Harald Wagner, Heimo Winkler
  • Patent number: 10695460
    Abstract: Subject of the invention is a composition comprising: (a) at least one film-forming polymer, which does not comprise silicon, (b) at least one organic UV filter, and (c) at least one organic solvent, wherein the composition is liquid at 20° C., wherein components (a) and (b) are dissolved in solvent (c), and wherein the ratio of the total amounts of organic UV filters (b) to film-forming polymers (a) is below 6.5. The invention also relates to compositions for therapy, uses of the composition, devices and methods.
    Type: Grant
    Filed: April 14, 2016
    Date of Patent: June 30, 2020
    Assignee: Siniq GmbH
    Inventors: Juerg Schmid, Andreas Supersaxo
  • Patent number: 10695295
    Abstract: Provided herein are dry pharmaceutical compositions for transmucosal delivery, comprising spray-dried particles that include pharmaceutically active agent nanoparticles, a binder, and a pharmaceutically acceptable carrier, where the active agent nanoparticles have an average particle size diameter prior to spray-drying of less than about 1 ?m, and wherein up to 10% of the spray-dried particles have a particle size of less than 10 ?m; at least 50% of the spray-dried particles have a particle size of at least about 15 ?m; and at least 90% of the spray-dried particles have a particle size of up to about 55 ?m. Also provided are methods for making such pharmaceutical compositions and therapeutic methods comprising transmucosally administering the compositions, such as intranasally or intravaginally.
    Type: Grant
    Filed: March 3, 2014
    Date of Patent: June 30, 2020
    Inventors: Maynard Emanuel Lichty, Garry T. Gwozdz
  • Patent number: 10695734
    Abstract: Provided herein are microcapsules as core-shell-particles, including a polymeric shell, a method of making them, a dispersion of the microcapsules in a liquid medium and a method of using thereof. The microcapsules include a core that contains a hydrophilic component.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: June 30, 2020
    Assignee: BASF SE
    Inventors: Yannick Fuchs, Helmut Witteler, Matthias Bratz
  • Patent number: 10687535
    Abstract: Described is a homogeneous gel composition with at least antimicrobial, antibacterial, and/or anti-viral properties comprising; a combination of a stable and homogeneous aqueous and/or polyol solution based chelated metal oxide liquid complex suspension and a gel composition free of chelated metal oxides comprising water, polyquaternium, glycerine and hyaluronic acid, wherein the homogeneous gel composition contains chelated metal oxide particles homogeneously suspended in the homogeneous gel composition such that a concentration of the chelated metal oxide particles contained within the homogeneous gel are in a concentration of at least 0.001 weight percent.
    Type: Grant
    Filed: November 14, 2014
    Date of Patent: June 23, 2020
    Assignee: AG Tech LLC
    Inventor: William Wingfield
  • Patent number: 10688047
    Abstract: Physically and chemically stable oral liquid formulations of Givinostat (Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride) are disclosed, together with methods for the preparation thereof. Such oral formulations are in the form of aqueous suspensions and contain Givinostat and/or pharmaceutically acceptable salts and/or derivatives thereof, at least a wetting agent and/or at least a density-imparting agent. Such formulations are suitable for oral administration for systemic therapeutic action.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: June 23, 2020
    Inventors: Giuseppe Colombo, Roberta Artico, Paolo Mascagni, Maria Valmen Monzani, Silvia Puccianti
  • Patent number: 10688042
    Abstract: A gel for topical application for alleviating food cravings is disclosed, which includes the steps of: periodically applying a gel topically to a user's skin, wherein said gel comprises: about 45.0 percent by weight of deionized water; about 10.0 percent by weight of benzyl alcohol; about 40.0 percent by weight of ethyl alcohol; about 0.2 percent by weight of tocopherol acetate; about 0.15 percent by weight of docosahexaenoic acid (DHA); about 1.15 percent by weight of resveratrol; about 1.0 percent by weight of a cross-linked polyacrylic acid copolymer; about 0.1 percent by weight of ethylenediaminetetraacetic acid (EDTA); about 200 ?L of lemon essential oil; and, from about 100 ?L to 200 ?L of triethanolamine.
    Type: Grant
    Filed: October 15, 2019
    Date of Patent: June 23, 2020
    Inventor: Antonino Cavallaro
  • Patent number: 10675229
    Abstract: Disclosed are compositions comprising inorganic UV-absorbing agents and the use of such compositions, in particular for protecting a subject or the surface of an inanimate object against a harmful effect of ultraviolet radiation.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: June 9, 2020
    Assignee: LANDA LABS (2012) LTD.
    Inventors: Benzion Landa, Sagi Abramovich, Snir Dor
  • Patent number: 10653822
    Abstract: The disclosure provides drug delivery devices and methods of making and using the drug delivery devices. The devices include single and multi-layer polymer films made by a breath figure technique having therapeutic agents associated therewith. For example, the devices may be a dual layer polymer film wherein the first layer includes a therapeutic agent incorporated into it by spin coating the first agent with a polymer solution and the second agent is incorporated into the second layer by loading the agent into pores of the second layer after it is spin coated onto the first layer. In some cases one layer provides a burst release and the second layer provides a slow release drug delivery profile. The devices may take on the form of a surgical mesh with a slow release therapeutic drug.
    Type: Grant
    Filed: August 11, 2018
    Date of Patent: May 19, 2020
    Inventors: Diane A. Blake, Vijay T. John, Ramesh Ayyala, Thiruselvam Ponnusamy
  • Patent number: 10646428
    Abstract: The invention relates to a cosmetic treatment process, in particular for caring for or making up keratin materials, comprising the following steps: a) a step of applying, to the keratin materials, a cosmetic composition comprising a compound comprising at least 2 maleimide groups; b) a step of applying a cosmetic composition comprising a compound comprising at least 2 furfuryl groups. The invention also relates to a kit comprising the two compositions, enabling said process to be carried out. The invention also relates to copolymers furfuryl (meth)acrylate, specifically (meth)acrylamide, and addition monomer chosen from polyethylene glycol (meth)acrylates and polydimethylsiloxanes with mono(meth)acryloyloxy end group.
    Type: Grant
    Filed: November 28, 2016
    Date of Patent: May 12, 2020
    Assignee: L'OREAL
    Inventors: Gwenaëlle Jegou, Philippe Barbarat, Gérard Malle
  • Patent number: 10610502
    Abstract: The present disclosure relates to aqueous oral solutions comprising baclofen. In one embodiment, the aqueous oral solutions comprise a buffer comprising citric acid, a salt of citric acid, or any combination thereof, and are stored at from about 2° C. to about 8° C. The present disclosure also relates to buffer free aqueous oral solutions comprising baclofen. Additionally, the present disclosure relates to an assay for determining the amount of an impurity, 4-(3-carboxymethyl)-3-hydroxy-2,5-dioxopyrrolidin-1-yl)-3-(4-chlorophenyl)butanoic acid, in a baclofen containing solution, and to methods of treatment using such aqueous oral solutions.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: April 7, 2020
    Assignee: Metacel Pharmaceuticals, LLC
    Inventors: Thomas Jeffrey Bryant, H. Greg Thomas
  • Patent number: 10588848
    Abstract: The present disclosure relates to cosmetic compositions that provide immediate skin-tightening and long-lasting improvements to the skin for the treatment of, for example, eye bags, facial wrinkles, and other age-related skin imperfections. The compositions comprise: (a) a first film former sodium silicate; (b) a second film former; (c) at least one polyvalent silicate; (d) at least one anionic associative polymeric thickener; (e) a third film former VP/VA Copolymer; (f) at least two plasticizer; (g) at least one treated or non treated iron oxide pigments; and (h) optionally at least one cosmetic powder.
    Type: Grant
    Filed: October 10, 2017
    Date of Patent: March 17, 2020
    Assignee: L'OREAL
    Inventors: Mariana Montoya, Angelike A. Galdi, Susan Halpern Chirch, Hubert Tunchiao Lam
  • Patent number: 10576023
    Abstract: A beauty care product is provided. The beauty care product has a multi-layered barrier patch with a non-foamed first layer and a foamed second layer. The non-foamed first layer has a non-foamed polymer film with a first surface and a thickness from 5 microns to 250 microns. The foamed second layer has a foamed polymer film comprising a Mean Void Volume Percentage from 45% to 80% and a thickness of from 10 microns to 250 microns. The beauty care product also has a cosmetic composition with an effective amount of a skin active agent and a pressure sensitive adhesive.
    Type: Grant
    Filed: October 18, 2016
    Date of Patent: March 3, 2020
    Assignee: The Procter & Gamble Company
    Inventors: Emily Charlotte Boswell, Elizabeth Anne Wilder, Michael Remus
  • Patent number: 10561608
    Abstract: Dry powder vancomycin compositions and methods for administering and preparing such compositions are provided.
    Type: Grant
    Filed: August 9, 2019
    Date of Patent: February 18, 2020
    Assignee: Savara Inc.
    Inventors: John Lord, Jaakko Taneli Jouhikainen, Herman E. Snyder, Pravin Soni, Mei-Chang Kuo
  • Patent number: 10556038
    Abstract: Provided are a dermal adhesive composed of a radiation-curable resin and capable of reducing stuffiness that causes rash or itch, a patch including the dermal adhesive, and a method for producing the dermal adhesive. Also provided is a porous membranous dermal adhesive formed through irradiation of a radiation-curable resin with radiation rays. Further provided is a patch including a base sheet and the dermal adhesive disposed on the base sheet. Still further provided is a method for producing a porous membranous dermal adhesive, the method including applying a dermal adhesive composition containing a radiation-curable resin to an adherend so as to form a porous membranous dermal adhesive, and irradiating the dermal adhesive composition with radiation rays.
    Type: Grant
    Filed: February 4, 2015
    Date of Patent: February 11, 2020
    Assignee: ALCARE CO., LTD
    Inventors: Ryota Watanabe, Wataru Okuyama